Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 9.04.
Forward PE Ratio (9.04) = Close Price ($276.04) / Consensus Forward EPS ($30.50)
FORWARD PE RATIO
9.04
SECTOR MEDIAN · HEALTHCARE
19.76
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
-54.24%
vs the sector median at left
Cigna Corporation
Market Cap
$72.94B
Forward PE Ratio
9.04
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Cigna Corporation (CI) | $72.94B | 9.04 |
| Boston Scientific Corporation (BSX)vs › | $67.12B | 13.62 |
| Cencora, Inc. (COR)vs › | $63.02B | 18.16 |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $83.12B | 14.93 |
| Elevance Health Inc. (ELV)vs › | $86.44B | 14.81 |
| Cardinal Health, Inc. (CAH)vs › | $55.92B | 22.32 |
| HCA Healthcare, Inc. (HCA)vs › | $91.74B | 13.64 |
| Moderna, Inc. (MRNA)vs › | $54.03B | N/A |
| Becton, Dickinson and Company (BDX)vs › | $49.60B | 14.14 |
| Edwards Lifesciences Corporation (EW)vs › | $49.42B | 28.90 |
Trailing P/E
11.4
reported TTM EPS
Forward P/E
9.0
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $30.50 implies +26.2% EPS growth vs the reported trailing $24.16.
At today's $276.04 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $30.50 | $30.44 – $30.57 | 14 | 9.1x |
| 2027-12-31 | $33.48 | $32.84 – $33.89 | 15 | 8.2x |
| 2028-12-31 | $37.09 | $30.46 – $40.23 | 10 | 7.4x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
